Cargando…
RASSF1A controls tissue stiffness and cancer stem‐like cells in lung adenocarcinoma
Lung cancer remains the leading cause of cancer‐related death due to poor treatment responses and resistance arising from tumour heterogeneity. Here, we show that adverse prognosis associated with epigenetic silencing of the tumour suppressor RASSF1A is due to increased deposition of extracellular m...
Autores principales: | Pankova, Daniela, Jiang, Yanyan, Chatzifrangkeskou, Maria, Vendrell, Iolanda, Buzzelli, Jon, Ryan, Anderson, Brown, Cameron, O'Neill, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600643/ https://www.ncbi.nlm.nih.gov/pubmed/31268606 http://dx.doi.org/10.15252/embj.2018100532 |
Ejemplares similares
-
RASSF1A is required for the maintenance of nuclear actin levels
por: Chatzifrangkeskou, Maria, et al.
Publicado: (2019) -
53BP1‐mediated recruitment of RASSF1A to ribosomal DNA breaks promotes local ATM signaling
por: Tsaridou, Stavroula, et al.
Publicado: (2022) -
Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion
por: Vlahov, Nikola, et al.
Publicado: (2015) -
RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?
por: Scrace, Simon F., et al.
Publicado: (2012) -
Clinical utility of RASSF1A methylation in human malignancies
por: Grawenda, A M, et al.
Publicado: (2015)